I am a talented finance leader with a proven track record of strategic financial leadership and process optimization in both business and commercial finance. I have over 20+ years of experience in Pharma at large and mid-size multinationals: Viatris, Pfizer, Novartis, Schering-Plough and possess in-depth knowledge of the US Healthcare system. I am a trusted business advisor to the CFO and Senior Executives known for delivering results, providing detailed analytical support and being a change agent. Led and built high-functioning finance teams in FP&A and Business Finance which enhanced decision making and drove significant efficiencies through process automation. Career Highlights:• History with managing a diverse pharmaceutical portfolio spanning Branded products, Biosimilars, Sterile Injectables and Generics.• Experience supporting M&A, Divestiture, and Alliance deals. Notable transactions are Pfizer's $17 billion acquisition of Hospira and Pfizer’s $12B spin-off of the Upjohn Division to Mylan.• Hands on experience across many areas of finance: Business Finance, FP&A, Pricing, Investor relations, Shared Services and interactions with: Controllership, Audit, Treasury.• Expertise with supporting ERP and EPM implementations and various analytical tools.